Norges Bank’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Norges Bank’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-553,300	Closed	-$1.89M	–	2320
2021 Q3	$1.89M	Buy	+553,300	New	+$1.71M	﹤0.01%	2059
2016 Q3	–	Sell	-402,625	Closed	-$536K	–	2176
2016 Q2	$536K	Sell	402,625 -97,467	-19%	-$456K	﹤0.01%	2118
2016 Q1	$2.64M	Hold	500,092	–	–	﹤0.01%	1965
2015 Q4	$3.93M	Hold	500,092	–	–	﹤0.01%	1914
2015 Q3	$4.23M	Buy	500,092 +182,013	+57%	+$1.68M	﹤0.01%	1887
2015 Q2	$3.48M	Buy	318,079 +29,700	+10%	+$381K	﹤0.01%	1968
2015 Q1	$4.03M	Buy	288,379 +42,461	+17%	+$649K	﹤0.01%	1948
2014 Q4	$4.15M	Sell	245,918 -97,373	-28%	-$1.42M	﹤0.01%	1962
2014 Q3	$4.61M	Sell	343,291 -343,291	-50%	-$4.09M	﹤0.01%	1941
2014 Q2	$8.75M	Buy	686,582 +343,291	+100%	+$3.58M	﹤0.01%	1980
2014 Q1	$4.08M	Hold	343,291	–	–	﹤0.01%	1935
2013 Q4	$4.74M	Hold	343,291	–	–	﹤0.01%	1912
2013 Q3	$5.99M	Buy	343,291 +99,963	+41%	+$1.91M	﹤0.01%	1828
2013 Q2	$3.95M	Buy	+243,328	New	+$7.53M	﹤0.01%	1942

Other funds holding INFI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Gratus Capital Atlanta, Georgia $2.5B AUM 32.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank's INFI Position: Q4 2021 in Review

Norges Bank sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2021, closing a stake of 553,300 shares — an estimated $1.89M sold.

Norges Bank first reported a position in INFI in Q2 2013 and held it in 14 quarters. The position peaked at $8.75M in Q2 2014. 97 funds tracked by Wall St. Rank hold INFI as of Q4 2021.

Norges Bank reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
Norges Bank sold 553,300 Infinity Pharmaceuticals, Inc. shares in Q4 2021, an estimated $1.89M.
Norges Bank first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 14 quarters.
Norges Bank's Infinity Pharmaceuticals, Inc. position peaked at $8.75M in Q2 2014.
97 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2021.

Based on Norges Bank's 13F filing for Q4 2021, filed 10 Feb 2022.